Harbor Investment Advisory’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.89K Hold
18
﹤0.01% 1155
2026
Q1
$3.3K Sell
18
-44
-71% -$8.11K ﹤0.01% 1072
2025
Q4
$10.9K Hold
62
﹤0.01% 923
2025
Q3
$8.69K Sell
62
-12
-16% -$1.62K ﹤0.01% 926
2025
Q2
$9.29K Buy
74
+56
+311% +$6.98K ﹤0.01% 901
2025
Q1
$2.46K Hold
18
﹤0.01% 1062
2024
Q4
$2.75K Sell
18
-74
-80% -$12.5K ﹤0.01% 1031
2024
Q3
$17.8K Sell
92
-18
-16% -$3.77K ﹤0.01% 765
2024
Q2
$25.5K Buy
110
+2
+2% +$435 ﹤0.01% 705
2024
Q1
$23.3K Buy
108
+29
+37% +$6.79K ﹤0.01% 716
2023
Q4
$20.4K Buy
79
+12
+18% +$2.95K ﹤0.01% 712
2023
Q3
$17.2K Hold
67
﹤0.01% 717
2023
Q2
$19.1K Hold
67
﹤0.01% 907
2023
Q1
$18.6K Hold
67
﹤0.01% 923
2022
Q4
$18.6K Hold
67
﹤0.01% 912
2022
Q3
$18K Hold
67
﹤0.01% 927
2022
Q2
$14K Sell
67
-25
-27% -$5.11K ﹤0.01% 966
2022
Q1
$19K Buy
92
+15
+19% +$3.26K ﹤0.01% 941
2021
Q4
$18K Sell
77
-82
-52% -$21.1K ﹤0.01% 951
2021
Q3
$45K Hold
159
0.01% 763
2021
Q2
$55K Sell
159
-456
-74% -$138K 0.01% 679
2021
Q1
$172K Sell
615
-339
-36% -$91.4K 0.03% 364
2020
Q4
$234K Sell
954
-464
-33% -$120K 0.04% 286
2020
Q3
$402K Sell
1,418
-200
-12% -$55.8K 0.08% 185
2020
Q2
$433K Sell
1,618
-82
-5% -$24.6K 0.09% 166
2020
Q1
$538K Buy
1,700
+14
+0.8% +$4.25K 0.14% 127
2019
Q4
$500K Buy
+1,686
New +$468K 0.12% 150

Other funds holding BIIB

Harbor Investment Advisory's BIIB Position: Q2 2026 in Review

Harbor Investment Advisory held its Biogen (BIIB) position steady in Q2 2026 at 18 shares worth $3.89K. The position accounts for ﹤0.01% of the portfolio, ranked #1155.

Harbor Investment Advisory first reported a position in BIIB in Q4 2019 and has held it in 27 quarters since. The position peaked at $538K in Q1 2020. 569 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Harbor Investment Advisory held 18 shares of Biogen worth $3.89K as of Q2 2026.
  • Harbor Investment Advisory left its Biogen share count unchanged in Q2 2026.
  • Biogen made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #1155 holding.
  • Harbor Investment Advisory first reported a position in Biogen in Q4 2019 and has held it in 27 quarters since.
  • Harbor Investment Advisory's Biogen position peaked at $538K in Q1 2020.
  • 569 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.